• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从查亚华塔原住民(秘鲁)传统药物圆锥泽兰中分离得到的抗利什曼原虫倍半萜内酯。第三部分。

Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III.

机构信息

CNRS - UMR Ecofog, Université des Antilles et de la Guyane, BP792, 97337 Cayenne cedex, France.

出版信息

J Ethnopharmacol. 2011 Sep 1;137(1):875-9. doi: 10.1016/j.jep.2011.07.008. Epub 2011 Jul 8.

DOI:10.1016/j.jep.2011.07.008
PMID:21771652
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

The study of traditional remedies used by the Chayahuita, an ethnic group from the Peruvian Amazonia, has prompted us to investigate in detail the ethanolic extract of Pseudelephantopus spicatus (Juss. ex Aubl.) C.F. Baker, which has demonstrated strong biological activity towards Leishmania amazonensis. Our goal was to discover the active compound of this plant-based remedy.

MATERIALS AND METHODS

A bioguided fractionation of the crude extract was undertaken based on the biological activity recorded against Leishmania amazonensis axenic amastigotes in in vitro bioassays.

RESULTS

Three strongly to moderately active compounds were isolated: two hirsutinolides (the 8,13-diacetyl-piptocarphol and the 8-acetyl-13-O-ethyl-piptocarphol) and ursolic acid. IC(50) against Leishmania amazonensis axenic amastigotes are respectively 0.2, 0.37 and 0.99 μM (while IC(50) of amphotericin B is 0.41 μM). These compounds have never been isolated from this plant species, and germacranolides have never been identified as potential antileishmanial agents.

CONCLUSIONS

The compounds isolated from Pseudelephantopus spicatus account for the antileishmanial activity of the plant, thus giving support to its use by the Chayahuita in Peru.

摘要

民族药理学相关性

对来自秘鲁亚马逊地区的 Chayahuita 民族使用的传统疗法的研究促使我们详细研究了 Pseudelephantopus spicatus(Juss. ex Aubl.)C.F. Baker 的乙醇提取物,该提取物对 Leishmania amazonensis 具有很强的生物活性。我们的目标是发现这种植物疗法的活性化合物。

材料和方法

根据体外生物测定中对 Leishmania amazonensis 无鞭毛体的生物活性,对粗提取物进行了生物导向的分级分离。

结果

分离出三种活性较强或中等的化合物:两种毛蕊花糖苷(8,13-二乙酰-刺桐醇和 8-乙酰-13-O-乙基-刺桐醇)和熊果酸。对 Leishmania amazonensis 无鞭毛体的 IC50 分别为 0.2、0.37 和 0.99 μM(而两性霉素 B 的 IC50 为 0.41 μM)。这些化合物从未从该植物种中分离出来,并且从未将倍半萜烯内酯鉴定为潜在的抗利什曼原虫药物。

结论

从 Pseudelephantopus spicatus 中分离出的化合物解释了该植物的抗利什曼活性,从而支持了 Chayahuita 在秘鲁使用该植物。

相似文献

1
Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III.从查亚华塔原住民(秘鲁)传统药物圆锥泽兰中分离得到的抗利什曼原虫倍半萜内酯。第三部分。
J Ethnopharmacol. 2011 Sep 1;137(1):875-9. doi: 10.1016/j.jep.2011.07.008. Epub 2011 Jul 8.
2
Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.从糙叶斑种草中分离得到的两种倍半萜内酯的抗寄生虫活性
J Ethnopharmacol. 2012 May 7;141(1):411-7. doi: 10.1016/j.jep.2012.03.002. Epub 2012 Mar 13.
3
Evaluation of antiplasmodial and antileishmanial activities of herbal medicine Pseudelephantopus spiralis (Less.) Cronquist and isolated hirsutinolide-type sesquiterpenoids.草药假地胆(Pseudelephantopus spiralis (Less.) Cronquist)及分离得到的刺毛醇内酯型倍半萜类化合物的抗疟和抗利什曼原虫活性评价
J Ethnopharmacol. 2015 Jul 21;170:167-74. doi: 10.1016/j.jep.2015.05.014. Epub 2015 May 14.
4
Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata.耳状母菊中抗锥虫型线性倍半萜内酯的抗锥虫、抗利什曼原虫和细胞毒性作用
Phytomedicine. 2009 Aug;16(8):783-7. doi: 10.1016/j.phymed.2008.12.008. Epub 2009 Feb 5.
5
In vitro antitrypanosomal and antileishmanial activity of plants used in Benin in traditional medicine and bio-guided fractionation of the most active extract.贝宁传统医学中使用的植物的体外抗锥虫和抗利什曼原虫活性及最活跃提取物的生物导向分离
J Ethnopharmacol. 2011 Sep 2;137(2):998-1002. doi: 10.1016/j.jep.2011.07.022. Epub 2011 Jul 18.
6
The antiprotozoal activity of sixteen asteraceae species native to Sudan and bioactivity-guided isolation of xanthanolides from Xanthium brasilicum.十六种原产于苏丹的菊科植物的抗原生动物活性和从 Xanthium brasilicum 中生物活性导向的 xanthanolides 分离。
Planta Med. 2009 Oct;75(12):1363-8. doi: 10.1055/s-0029-1185676. Epub 2009 May 8.
7
Antitrypanosomal sesquiterpene lactones from Saussurea costus.来自雪莲的抗锥虫倍半萜内酯。
Fitoterapia. 2011 Oct;82(7):955-9. doi: 10.1016/j.fitote.2011.05.010. Epub 2011 May 23.
8
Ta'ta', Huayani: perception of leishmaniasis and evaluation of medicinal plants used by the Chayahuita in Peru. Part II.塔塔,瓦亚尼:利什曼病的认知和秘鲁恰亚维塔人使用药用植物的评估。第二部分。
J Ethnopharmacol. 2009 Oct 29;126(1):149-58. doi: 10.1016/j.jep.2009.07.015. Epub 2009 Jul 23.
9
Cytotoxic sesquiterpene lactones from Pseudoelephantopus spicatus.来自假地胆草的细胞毒性倍半萜内酯。
J Nat Prod. 2007 Nov;70(11):1761-5. doi: 10.1021/np070331q. Epub 2007 Oct 31.
10
Isolation and identification of antiplasmodial sesquiterpene lactones from Oncosiphon piluliferum.从胶须藻中分离和鉴定抗疟倍半萜内酯
J Ethnopharmacol. 2007 May 30;112(1):71-6. doi: 10.1016/j.jep.2007.02.002. Epub 2007 Feb 9.

引用本文的文献

1
Natural resources used in the traditional medicine of the Marinaú community, Caxiuanã forest, Brazil.巴西卡西亚纳森林马里瑙社区传统医学中使用的自然资源。
Front Pharmacol. 2024 Oct 9;15:1443360. doi: 10.3389/fphar.2024.1443360. eCollection 2024.
2
Semisynthetic Sesquiterpene Lactones Generated by the Sensibility of Glaucolide B to Lewis and Brønsted-Lowry Acids and Bases: Cytotoxicity and Anti-Inflammatory Activities.半合成倍半萜内酯由 Glaucolide B 对路易斯酸和布朗斯特-劳里酸碱的敏感性产生:细胞毒性和抗炎活性。
Molecules. 2023 Jan 27;28(3):1243. doi: 10.3390/molecules28031243.
3
The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade.
对抗利什曼病中潜在有效药物的探索:过去十年天然产物的贡献
Nat Prod Bioprospect. 2021 Oct;11(5):489-544. doi: 10.1007/s13659-021-00311-2. Epub 2021 Jul 14.
4
The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.传统知识在开发治疗利什曼病有效药物方面的潜力。
Front Pharmacol. 2021 Jun 8;12:690432. doi: 10.3389/fphar.2021.690432. eCollection 2021.
5
Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.评估熊果酸作为治疗皮肤利什曼病和内脏利什曼病的生物制品的潜力。
Molecules. 2020 Mar 19;25(6):1394. doi: 10.3390/molecules25061394.
6
Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease.菊科植物作为抗利什曼病和恰加斯病化合物的来源。
Front Pharmacol. 2019 May 8;10:477. doi: 10.3389/fphar.2019.00477. eCollection 2019.
7
Simultaneous HPTLC analysis and antileishmanic activity of various secondary metabolites in extract of the traditional medicinal herb (L.f.).传统药草(L.f.)提取物中多种次生代谢产物的同步高效薄层色谱分析及抗利什曼活性
Ayu. 2018 Apr-Jun;39(2):92-100. doi: 10.4103/ayu.AYU_158_17.
8
Three new trixane glycosides obtained from the leaves of Jungia sellowii Less. using centrifugal partition chromatography.利用离心分配色谱法从黄氏容吉草(Jungia sellowii Less.)叶片中获得了三种新的三亚甲基己烷糖苷。
Beilstein J Org Chem. 2016 Apr 12;12:674-83. doi: 10.3762/bjoc.12.68. eCollection 2016.
9
Cytotoxicity potentials of eleven Bangladeshi medicinal plants.十一种孟加拉药用植物的细胞毒性潜力
ScientificWorldJournal. 2014;2014:913127. doi: 10.1155/2014/913127. Epub 2014 Nov 9.
10
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.利什曼病和人类非洲锥虫病药物研发的最新进展。
Chem Rev. 2014 Nov 26;114(22):11305-47. doi: 10.1021/cr500365f. Epub 2014 Nov 3.